BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 37004837)

  • 21. Baseline MRI-Radiomics Can Predict Overall Survival in Non-Endemic EBV-Related Nasopharyngeal Carcinoma Patients.
    Bologna M; Corino V; Calareso G; Tenconi C; Alfieri S; Iacovelli NA; Cavallo A; Cavalieri S; Locati L; Bossi P; Romanello DA; Ingargiola R; Rancati T; Pignoli E; Sdao S; Pecorilla M; Facchinetti N; Trama A; Licitra L; Mainardi L; Orlandi E
    Cancers (Basel); 2020 Oct; 12(10):. PubMed ID: 33066161
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Machine Learning Based Radiomic HPV Phenotyping of Oropharyngeal SCC: A Feasibility Study Using MRI.
    Sohn B; Choi YS; Ahn SS; Kim H; Han K; Lee SK; Kim J
    Laryngoscope; 2021 Mar; 131(3):E851-E856. PubMed ID: 33070337
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improved outcome prediction of oropharyngeal cancer by combining clinical and MRI features in machine learning models.
    Bos P; van den Brekel MWM; Gouw ZAR; Al-Mamgani A; Taghavi M; Waktola S; Aerts HJWL; Castelijns JA; Beets-Tan RGH; Jasperse B
    Eur J Radiol; 2021 Jun; 139():109701. PubMed ID: 33865064
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Computed Tomography Radiomics Predicts HPV Status and Local Tumor Control After Definitive Radiochemotherapy in Head and Neck Squamous Cell Carcinoma.
    Bogowicz M; Riesterer O; Ikenberg K; Stieb S; Moch H; Studer G; Guckenberger M; Tanadini-Lang S
    Int J Radiat Oncol Biol Phys; 2017 Nov; 99(4):921-928. PubMed ID: 28807534
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Establishment and validation of novel MRI radiomic feature-based prognostic models to predict progression-free survival in locally advanced rectal cancer.
    Xie F; Zhao Q; Li S; Wu S; Li J; Li H; Chen S; Jiang W; Dong A; Wu L; Liu L; Huang H; Xu S; Shao Y; Liu L; Li L; Cai P
    Front Oncol; 2022; 12():901287. PubMed ID: 36408187
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Whole-Volume Tumor MRI Radiomics for Prognostic Modeling in Endometrial Cancer.
    Fasmer KE; Hodneland E; Dybvik JA; Wagner-Larsen K; Trovik J; Salvesen Ø; Krakstad C; Haldorsen IHS
    J Magn Reson Imaging; 2021 Mar; 53(3):928-937. PubMed ID: 33200420
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Computed tomography-derived radiomic signature of head and neck squamous cell carcinoma (peri)tumoral tissue for the prediction of locoregional recurrence and distant metastasis after concurrent chemo-radiotherapy.
    Keek S; Sanduleanu S; Wesseling F; de Roest R; van den Brekel M; van der Heijden M; Vens C; Giuseppina C; Licitra L; Scheckenbach K; Vergeer M; Leemans CR; Brakenhoff RH; Nauta I; Cavalieri S; Woodruff HC; Poli T; Leijenaar R; Hoebers F; Lambin P
    PLoS One; 2020; 15(5):e0232639. PubMed ID: 32442178
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preoperative computed tomography-guided disease-free survival prediction in gastric cancer: a multicenter radiomics study.
    Wang S; Feng C; Dong D; Li H; Zhou J; Ye Y; Liu Z; Tian J; Wang Y
    Med Phys; 2020 Oct; 47(10):4862-4871. PubMed ID: 32592224
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Noninvasive prediction of residual disease for advanced high-grade serous ovarian carcinoma by MRI-based radiomic-clinical nomogram.
    Li H; Zhang R; Li R; Xia W; Chen X; Zhang J; Cai S; Li Y; Zhao S; Qiang J; Peng W; Gu Y; Gao X
    Eur Radiol; 2021 Oct; 31(10):7855-7864. PubMed ID: 33864139
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radiomic signature-based nomogram to predict disease-free survival in stage II and III colon cancer.
    Yao X; Sun C; Xiong F; Zhang X; Cheng J; Wang C; Ye Y; Hong N; Wang L; Liu Z; Meng X; Wang Y; Tian J
    Eur J Radiol; 2020 Oct; 131():109205. PubMed ID: 32871292
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radiomic Profiling of Glioblastoma: Identifying an Imaging Predictor of Patient Survival with Improved Performance over Established Clinical and Radiologic Risk Models.
    Kickingereder P; Burth S; Wick A; Götz M; Eidel O; Schlemmer HP; Maier-Hein KH; Wick W; Bendszus M; Radbruch A; Bonekamp D
    Radiology; 2016 Sep; 280(3):880-9. PubMed ID: 27326665
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of Lymph Node Metastasis in Advanced Gastric Cancer Using Magnetic Resonance Imaging-Based Radiomics.
    Chen W; Wang S; Dong D; Gao X; Zhou K; Li J; Lv B; Li H; Wu X; Fang M; Tian J; Xu M
    Front Oncol; 2019; 9():1265. PubMed ID: 31824847
    [No Abstract]   [Full Text] [Related]  

  • 33. An MRI-Based Radiomic Model for Individualized Prediction of Hepatocellular Carcinoma in Patients With Hepatitis B Virus-Related Cirrhosis.
    Wei Y; Gong J; He X; Liu B; Liu T; Yang S; Zhou Z; Liang L; Zhan S; Xia Z; Duan G; Lin B; Han Q; Li S; Qin W; Pickhardt PJ; Deng D
    Front Oncol; 2022; 12():800787. PubMed ID: 35359425
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Radiomics Profiling Identifies the Incremental Value of MRI Features beyond Key Molecular Biomarkers for the Risk Stratification of High-Grade Gliomas.
    Yang G; Sha Y; Wang X; Tan Y; Zhang H
    Contrast Media Mol Imaging; 2022; 2022():8952357. PubMed ID: 35386727
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MRI-Based Radiomic Signature as a Prognostic Biomarker for HER2-Positive Invasive Breast Cancer Treated with NAC.
    Li Q; Xiao Q; Li J; Duan S; Wang H; Gu Y
    Cancer Manag Res; 2020; 12():10603-10613. PubMed ID: 33149669
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A multi-sequence and habitat-based MRI radiomics signature for preoperative prediction of MGMT promoter methylation in astrocytomas with prognostic implication.
    Wei J; Yang G; Hao X; Gu D; Tan Y; Wang X; Dong D; Zhang S; Wang L; Zhang H; Tian J
    Eur Radiol; 2019 Feb; 29(2):877-888. PubMed ID: 30039219
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Radiomic profiling for insular diffuse glioma stratification with distinct biologic pathway activities.
    Duan W; Wang Z; Ma Z; Zheng H; Li Y; Pei D; Wang M; Qiu Y; Duan M; Yan D; Ji Y; Cheng J; Liu X; Zhang Z; Yan J
    Cancer Sci; 2024 Apr; 115(4):1261-1272. PubMed ID: 38279197
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study.
    Sun R; Limkin EJ; Vakalopoulou M; Dercle L; Champiat S; Han SR; Verlingue L; Brandao D; Lancia A; Ammari S; Hollebecque A; Scoazec JY; Marabelle A; Massard C; Soria JC; Robert C; Paragios N; Deutsch E; Ferté C
    Lancet Oncol; 2018 Sep; 19(9):1180-1191. PubMed ID: 30120041
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development and validation of a prognostic nomogram for malignant esophageal fistula based on radiomics and clinical factors.
    Zhu C; Ding J; Wang S; Qiu Q; Ji Y; Wang L
    Thorac Cancer; 2021 Dec; 12(23):3110-3120. PubMed ID: 34647417
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MRI Radiomic Features: Association with Disease-Free Survival in Patients with Triple-Negative Breast Cancer.
    Kim S; Kim MJ; Kim EK; Yoon JH; Park VY
    Sci Rep; 2020 Feb; 10(1):3750. PubMed ID: 32111957
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.